Published in Blood Cancer J on February 11, 2011
Differentiation Induction in Acute Myelogenous Leukemia | NCT00175812
Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy. Leukemia (2014) 1.28
Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agents. Clin Epigenetics (2013) 0.93
Finding New Order in Biological Functions from the Network Structure of Gene Annotations. PLoS Comput Biol (2015) 0.80
Increased SYK activity is associated with unfavorable outcome among patients with acute myeloid leukemia. Oncotarget (2015) 0.77
Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms. Front Immunol (2017) 0.75
Targeted Therapy of FLT3 in Treatment of AML-Current Status and Future Directions. J Clin Med (2014) 0.75
Elevated monocyte phosphorylated p38 in nearby employees after a chemical explosion. Sci Rep (2016) 0.75
Anti-proliferative activity of the NPM1 interacting natural product avrainvillamide in acute myeloid leukemia. Cell Death Dis (2016) 0.75
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukaemia treated with nilotinib. Haematologica (2017) 0.75
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
Acute myeloid leukaemia. Lancet (2006) 7.74
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J (2001) 6.85
Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell (2004) 6.24
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nat Methods (2006) 5.25
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid. Blood (2004) 2.23
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia. Cancer (2005) 1.38
A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia. Clin Cancer Res (2006) 1.34
Acute myeloid leukemia: the challenge of capturing disease variety. Hematology Am Soc Hematol Educ Program (2008) 1.28
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. Leukemia (2009) 1.14
Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes. Toxicol Sci (2005) 1.11
Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways. Blood (2004) 1.05
Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia. Haematologica (2005) 1.03
Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy. Am J Pathol (2009) 1.00
Valproic acid and all-trans retinoic acid: meta-analysis of a palliative treatment regimen in AML and MDS patients. Onkologie (2008) 0.94
Targeted therapy in acute myeloid leukaemia: current status and future directions. Expert Opin Investig Drugs (2009) 0.94
In vivo biological effects of ATRA in the treatment of AML. Expert Opin Investig Drugs (2008) 0.92
Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase. Biochem J (2002) 0.92
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998). Leukemia (2004) 0.88
Clinical proteomics of myeloid leukemia. Genome Med (2010) 0.82
Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochem Pharmacol (1992) 0.82
Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia. Leuk Res (2009) 0.81
Regulation of the synthesis of bcl-2 protein by growth factors. Leukemia (1996) 0.80
Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases. Bone Marrow Transplant (2002) 0.80
Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia. BMC Cancer (2009) 0.79
The InterPro database, an integrated documentation resource for protein families, domains and functional sites. Nucleic Acids Res (2001) 24.45
InterPro--an integrated documentation resource for protein families, domains and functional sites. Bioinformatics (2000) 6.42
Structure comparison and structure patterns. J Comput Biol (2000) 5.73
Predicting gene regulatory elements in silico on a genomic scale. Genome Res (1998) 4.52
J-Express: exploring gene expression data using Java. Bioinformatics (2001) 3.82
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes (2000) 3.74
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation. Proc Natl Acad Sci U S A (2009) 2.72
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet (1991) 2.72
Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet (1997) 1.94
Fine mapping of 28S rRNA sites specifically cleaved in cells undergoing apoptosis. Mol Cell Biol (1995) 1.78
Mining for putative regulatory elements in the yeast genome using gene expression data. Proc Int Conf Intell Syst Mol Biol (2000) 1.73
Approaches to the automatic discovery of patterns in biosequences. J Comput Biol (1998) 1.62
Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in cancer cell. Curr Pharm Biotechnol (2007) 1.61
The protein phosphatase inhibitor okadaic acid induces morphological changes typical of apoptosis in mammalian cells. Exp Cell Res (1991) 1.55
Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. Br J Haematol (2001) 1.49
Erythropoietin a safe bet in haemorrhagic shock? Acta Anaesthesiol Scand (2008) 1.39
[A management program for primary thrombocytopenia]. Tidsskr Nor Laegeforen (1999) 1.38
New strategies in the treatment of acute myelogenous leukemia: mobilization and transplantation of autologous peripheral blood stem cells in adult patients. Stem Cells (2000) 1.38
Crystal and molecular structure of chymotrypsin inhibitor 2 from barley seeds in complex with subtilisin Novo. Proc Natl Acad Sci U S A (1985) 1.31
Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J (1995) 1.28
The genetic subtypes of cAMP-dependent protein kinase--functionally different or redundant? Biochim Biophys Acta (1993) 1.17
Review: genetic models of acute myeloid leukaemia. Oncogene (2008) 1.14
Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate-kinase I in a myeloid leukemia cell line. J Cell Physiol (1991) 1.12
Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. Leukemia (2011) 1.11
Ultrarapid caspase-3 dependent apoptosis induction by serine/threonine phosphatase inhibitors. Cell Death Differ (1999) 1.06
Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue. J Pharm Sci (1997) 1.03
Heat shock protein 90 - a potential target in the treatment of human acute myelogenous leukemia. Curr Cancer Drug Targets (2009) 1.02
Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs. Diabetologia (1996) 1.02
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients. Leukemia (2013) 1.00
Animal models of acute myelogenous leukaemia - development, application and future perspectives. Leukemia (2005) 0.99
Albumin binding and time action of acylated insulins in various species. J Pharm Sci (1996) 0.98
Coronally positioned flap procedures with or without a bioabsorbable membrane in the treatment of human gingival recession. J Periodontol (2000) 0.97
Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia. Oncogene (2011) 0.96
Caspase-dependent, geldanamycin-enhanced cleavage of co-chaperone p23 in leukemic apoptosis. Leukemia (2004) 0.95
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer (1994) 0.95
New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches. Stem Cells (2001) 0.94
Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report. Leukemia (2006) 0.93
A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients. Neuropathol Appl Neurobiol (2011) 0.92
Microinjected catalytic subunit of cAMP-dependent protein kinase induces apoptosis in myeloid leukemia (IPC-81) cells. Exp Cell Res (1993) 0.92
Patterns of cell death induced by eluates from denture base acrylic resins in U-937 human monoblastoid cells. Eur J Oral Sci (2000) 0.90
8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line. Br J Cancer (1995) 0.90
CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation. Cell Death Differ (2005) 0.90
Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP. Biochem Biophys Res Commun (1997) 0.90
Catha edulis (Khat) induces cell death by apoptosis in leukemia cell lines. Ann N Y Acad Sci (2003) 0.90
Antiapoptotic effect of heterozygously expressed mutant RI (Ala336-->Asp) subunit of cAMP kinase I in a rat leukemia cell line. J Biol Chem (1993) 0.90
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis. Cell Death Dis (2013) 0.89
Characterization of human tissue factor pathway inhibitor variants expressed in Saccharomyces cerevisiae. J Biol Chem (1993) 0.89
Khat (Catha edulis)-induced apoptosis is inhibited by antagonists of caspase-1 and -8 in human leukaemia cells. Br J Cancer (2004) 0.88
Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation. Cell Death Differ (2012) 0.88
Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor. Diabetes Obes Metab (2010) 0.87
In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines. J Hematother Stem Cell Res (2000) 0.86
Preliminary crystallographic data for the serine protease inhibitor CI-2 from barley seeds. J Mol Biol (1983) 0.86
Insulin-like growth factor-1 (IGF-1) has a costimulatory effect on proliferation of committed progenitors derived from human umbilical cord CD34+ cells. Stem Cells (1998) 0.85
Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. J Eur Acad Dermatol Venereol (1998) 0.85
Tunneling nanotube (TNT) formation is independent of p53 expression. Cell Death Differ (2013) 0.84
Crystal structure of a prolonged-acting insulin with albumin-binding properties. Biochemistry (1997) 0.84
Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scand J Immunol (2004) 0.84
Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells. Transfusion (2005) 0.84
Implications of cell death regulation in the pathogenesis and treatment of prostate cancer. Semin Oncol (1999) 0.83
Identification of four SB antigens by cloned cells. Population studies of Norwegians. Tissue Antigens (1983) 0.83
Discovering patterns and subfamilies in biosequences. Proc Int Conf Intell Syst Mol Biol (1996) 0.83
Restoration of bax in prostate cancer suppresses tumor growth and augments therapeutic cell death induction. Anticancer Res (2002) 0.83
No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematother Stem Cell Res (2003) 0.82
HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with type 1 (insulin-dependent) diabetes and healthy subjects. Diabetologia (1985) 0.82
New strategies for the treatment of acute myelogenous leukemia: differentiation induction--present use and future possibilities. Stem Cells (2000) 0.82
PHF6 Deletions May Cause Borjeson-Forssman-Lehmann Syndrome in Females. Mol Syndromol (2011) 0.82
Tiling resolution array CGH of dic(7;9)(p11 approximately 13;p11 approximately 13) in B-cell precursor acute lymphoblastic leukemia reveals clustered breakpoints at 7p11.2 approximately 12.1 and 9p13.1. Cytogenet Genome Res (2007) 0.81
Induction of differentiation and apoptosis- a possible strategy in the treatment of adult acute myelogenous leukemia. Oncologist (2000) 0.81
In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts. Eur J Haematol (1999) 0.81
Ribosomal proteins sustain morphology, function and phenotype in acute myeloid leukemia blasts. Leuk Res (1998) 0.81
Mycobacterium tuberculosis Mce1 protein complex initiates rapid induction of transcription of genes involved in substrate trafficking. Genes Immun (2012) 0.81
Caspase I-related protease inhibition retards the execution of okadaic acid- and camptothecin-induced apoptosis and PAI-2 cleavage, but not commitment to cell death in HL-60 cells. Br J Cancer (1999) 0.81
T lymphocyte responses to Coxsackie B4 and mumps virus. I. Influence of HLA-DR restriction elements. Tissue Antigens (1985) 0.80
Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases. Bone Marrow Transplant (2002) 0.80
Loss-of-Function CNKSR2 Mutation Is a Likely Cause of Non-Syndromic X-Linked Intellectual Disability. Mol Syndromol (2011) 0.80
Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha. Leuk Lymphoma (1995) 0.79
Plasma desorption mass spectrometry, an analytical tool in protein engineering: characterization of modified insulins. Protein Eng (1989) 0.79
Sensitive and rapid detection of beta-galactosidase expression in intact cells by microinjection of fluorescent substrate. Exp Cell Res (1995) 0.79
Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients. Cell Prolif (2013) 0.79
The role of the CD8-positive subset of T cells in proliferative responses to soluble antigens. I. Studies of healthy subjects, type 1 diabetics, and coeliac disease patients. Scand J Immunol (1986) 0.79
Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin. Acta Pathol Microbiol Immunol Scand C (1986) 0.79
Gap junctions and growth control in liver regeneration and in isolated rat hepatocytes. Hepatology (1997) 0.78
The surface molecule signature of primary human acute myeloid leukemia (AML) cells is highly associated with NPM1 mutation status. Leukemia (2011) 0.78
Circadian variations do not have a major impact on serum levels of soluble (S) L-selectin (CD63L), S-intercellular adhesion molecule 1 (sICAM-1/CD54) and thrombopoietin in healthy individuals. Scand J Clin Lab Invest (2002) 0.78
The effect of heat- and auto-polymerized denture base polymers on clonogenicity, apoptosis, and necrosis in fibroblasts: denture base polymers induce apoptosis and necrosis. Acta Odontol Scand (2000) 0.78
HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus. Studies of healthy individuals and patients with type 1 diabetes. Scand J Immunol (1985) 0.77
T lymphocyte responses to Coxsackie B4 and mumps virus. II. Immunoregulation by HLA-DR3 and -DR4 associated restriction elements. Tissue Antigens (1985) 0.77